The effect of cigarette smoking on cancer treatment-related side effects.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 3248778)

Published in Oncologist on December 01, 2011

Authors

Luke J Peppone1, Karen M Mustian, Gary R Morrow, Ann M Dozier, Deborah J Ossip, Michelle C Janelsins, Lisa K Sprod, Scott McIntosh

Author Affiliations

1: Department of Radiation Oncology, University of Rochester, Rochester, New York 14642, USA. luke_peppone@urmc.rochester.edu

Associated clinical trials:

Vitamin D Oral Gel for Prevention of Radiation Induced Oral Mucositis | NCT04308161

Articles cited by this

Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28

Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med (2005) 33.60

Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol (2005) 7.57

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer (2000) 7.25

The prevalence of psychiatric disorders among cancer patients. JAMA (1983) 5.48

Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol (2000) 4.96

Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr (2004) 4.37

Chemotherapy-induced nausea and vomiting. N Engl J Med (2008) 4.00

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst (1998) 3.67

Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med (1993) 3.61

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer (2004) 3.50

Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer (2006) 3.23

Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer (2006) 3.14

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol (2002) 3.13

Cancer-related fatigue: the scale of the problem. Oncologist (2007) 3.03

Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer (2000) 2.87

Dose: a critical factor in cancer chemotherapy. Am J Med (1980) 2.82

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer (1999) 2.68

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst (2006) 2.61

Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol (2009) 2.38

Mechanisms of cancer-related fatigue. Oncologist (2007) 2.25

Long-term trends in cancer mortality in the United States, 1930-1998. Cancer (2003) 2.18

Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr (2004) 2.00

Sleep disturbance in cancer patients. Soc Sci Med (2002) 1.99

Lifestyle interventions in cancer survivors: designing programs that meet the needs of this vulnerable and growing population. J Nutr (2007) 1.85

Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76

Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer (1979) 1.75

Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73

The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev (2001) 1.50

Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points? J Pain Symptom Manage (2007) 1.46

Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer (1995) 1.45

Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics (2007) 1.44

Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage (2005) 1.37

Emerging issues in smoking among adolescent and adult cancer survivors: a comprehensive review. Cancer (2007) 1.37

Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol (2009) 1.34

Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control (1991) 1.34

The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology (2007) 1.31

Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol (2002) 1.30

Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer (2005) 1.28

First year after head and neck cancer: quality of life. J Clin Oncol (1999) 1.22

The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns (2007) 1.21

Smoking cessation and lung cancer resection. Chest (1996) 1.21

Predictors of morbidity following free flap reconstruction for cancer of the head and neck. Head Neck (2007) 1.19

Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr (2004) 1.18

Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices. Cancer (2004) 1.16

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol (2001) 1.06

Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results. Psychooncology (2009) 1.00

Impact of nausea/vomiting on quality of life as a visual analogue scale-derived utility score. Support Care Cancer (1996) 0.99

Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys (2008) 0.98

A process evaluation of a telephone-based peer-delivered smoking cessation intervention for adult survivors of childhood cancer: the partnership for health study. Prev Med (2006) 0.97

Availability of smoking prevention and cessation services for childhood cancer survivors. Cancer Causes Control (2007) 0.94

The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg (1987) 0.94

Content validity of self-report measurement instruments: an illustration from the development of the Brain Tumor Module of the M.D. Anderson Symptom Inventory. Oncol Nurs Forum (2005) 0.93

Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Support Care Cancer (2006) 0.93

Colorectal cancer occurs earlier in those exposed to tobacco smoke: implications for screening. J Cancer Res Clin Oncol (2008) 0.88

Effect of short-term smoking halt on carboxyhemoglobin levels and P50 values. Anesth Analg (1986) 0.86

Antiemesis. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2009) 0.84

Fatigue and depression in cancer patients undergoing chemotherapy: an emotion approach. J Pain Symptom Manage (2006) 0.78

Chemotherapy: what to do about special side effects. RN (1977) 0.77

The clinical application of drug dosing schedules in cancer therapy--Part II. Cancer Nurs (1984) 0.76

Behavioral side effects of adjuvant chemotherapy. Recent Results Cancer Res (1989) 0.76

Articles by these authors

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol (2006) 4.97

Quitlines in North America: evidence base and applications. Am J Med Sci (2003) 3.35

Cancer-related fatigue: the scale of the problem. Oncologist (2007) 3.03

Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy. J Clin Oncol (2012) 3.03

A survey of the use of ultrasound during central venous catheterization. Anesth Analg (2007) 2.69

The influence of public reporting of outcome data on medical decision making by physicians. Arch Intern Med (2005) 2.40

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.39

Mechanisms of cancer-related fatigue. Oncologist (2007) 2.25

Community-based clinical oncology research trials for cancer-related fatigue. J Support Oncol (2006) 2.01

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer (2003) 1.98

Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.98

Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76

Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73

Clinical and translational scientist career success: metrics for evaluation. Clin Transl Sci (2012) 1.61

Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst (2009) 1.56

Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer (2001) 1.52

Cancer-related fatigue and sleep disorders. Oncologist (2007) 1.47

Evaluation of current tobacco curriculum at 12 US medical schools. J Cancer Educ (2004) 1.47

Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol (2013) 1.46

5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol (2005) 1.43

Tobacco cessation and prevention practices reported by second and fourth year students at US medical schools. J Gen Intern Med (2008) 1.40

Traumatic stress symptoms among women with recently diagnosed primary breast cancer. J Trauma Stress (2002) 1.40

Acustimulation wristbands for the relief of chemotherapy-induced nausea. Altern Ther Health Med (2002) 1.39

Age and sex differences between patient and physician-derived outcome measures in the foot and ankle. J Bone Joint Surg Am (2013) 1.38

Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage (2005) 1.37

Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist (2007) 1.36

Web-assisted tobacco interventions: empowering change in the global fight for the public's (e)Health. J Med Internet Res (2008) 1.36

Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer (2004) 1.34

Social network analysis as a method of assessing institutional culture: three case studies. Acad Med (2009) 1.33

An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32

Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist (2007) 1.32

Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30

Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment. Cancer (2007) 1.29

Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer (2005) 1.28

Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer (2009) 1.28

Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat (2005) 1.24

Perceived discrimination, psychological distress, and current smoking status: results from the Behavioral Risk Factor Surveillance System Reactions to Race module, 2004-2008. Am J Public Health (2012) 1.23

Cancer survivorship and aging : moving the science forward. Cancer (2008) 1.23

What are successful recruitment and retention strategies for underserved populations? Examining physical activity interventions in primary care and community settings. Transl Behav Med (2011) 1.20

A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer (2010) 1.19

Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer (2011) 1.19

Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices. Cancer (2004) 1.16

Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base. J Clin Oncol (2012) 1.15

Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia (2009) 1.15

Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program. Support Cancer Ther (2004) 1.14

Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw (2007) 1.13

The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage (2003) 1.13

A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study. Support Cancer Ther (2007) 1.13

Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology (2005) 1.13

Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Support Care Cancer (2013) 1.12

Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors. Clin Breast Cancer (2011) 1.11

A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. J Support Oncol (2009) 1.11

The use of Spanish by medical students and residents at one university hospital. Acad Med (2006) 1.10

Anticipatory nausea and vomiting. Support Care Cancer (2010) 1.09

Tobacco use in six economically disadvantaged communities in the Dominican Republic. Nicotine Tob Res (2008) 1.08

Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer (2011) 1.07

Addressing Family Smoking in Child Health Care Settings. J Clin Outcomes Manag (2009) 1.04

Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. J Clin Sleep Med (2008) 1.04

Exercise training manages cardiopulmonary function and fatigue during and following cancer treatment in male cancer survivors. Integr Cancer Ther (2007) 1.02

IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest (2010) 1.02

The Clinical Effort Against Secondhand Smoke Exposure (CEASE) Intervention: A Decade of Lessons Learned. J Clin Outcomes Manag (2012) 1.01

Interleukin 1beta (IL1B) signaling is a critical component of radiation-induced skin fibrosis. Radiat Res (2006) 1.01

The effect of modafinil on cognitive function in breast cancer survivors. Cancer (2009) 1.00

The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels. Ann Surg Oncol (2012) 1.00

Exercise for the management of side effects and quality of life among cancer survivors. Curr Sports Med Rep (2009) 0.99

Tobacco is a global paediatric concern. Bull World Health Organ (2010) 0.99

Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a university of Rochester cancer center community clinical oncology program study. J Pain Symptom Manage (2008) 0.98

Cancer-related stress and complementary and alternative medicine: a review. Evid Based Complement Alternat Med (2012) 0.98

Accrual and recruitment practices at Clinical and Translational Science Award (CTSA) institutions: a call for expectations, expertise, and evaluation. Acad Med (2014) 0.98

Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial. Psychooncology (2008) 0.98

Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat (2004) 0.97

The current state of personal training: an industry perspective of personal trainers in a small Southeast community. J Strength Cond Res (2008) 0.97

Clinician-patient communication about physical activity in an underserved population. J Am Board Fam Med (2008) 0.97

Health care workers in the Dominican Republic: self-perceived role in smoking cessation. Eval Health Prof (2009) 0.95

Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial. Clin Breast Cancer (2010) 0.94

The effect of various vitamin D supplementation regimens in breast cancer patients. Breast Cancer Res Treat (2011) 0.94

Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Support Care Cancer (2006) 0.93

Delayed onset lactogenesis II predicts the cessation of any or exclusive breastfeeding. J Pediatr (2012) 0.93

Racial disparities in traumatic stress in prostate cancer patients: secondary analysis of a National URCC CCOP Study of 317 men. Support Care Cancer (2010) 0.93